Cipla launches quality-assured Rectal Artesunate Suppositories for severe malaria in young children

Cipla Announces Collaboration with MEDRx

Cipla USA enters into a collaboration with MEDRx

Cipla Receives Final Approval for Generic Epzicom® Tablets

Cipla agrees to divest its animal health business in South Africa and Sub-Saharan Africa

Cipla launches Hepatitis B vaccine in India

Cipla appoints Peter Lankau as an Independent Director on its Board

Cipla’s Flagship Product Sereflo™ Receives Final Approval from UK MHRA

Cipla Receives Final Approval for Generic Tricor® Tablets

Cipla appoints Ireena Vittal as an Independent Director on its Board